EP1487783A4 - Modulateurs irreversibles selectifs de recepteur d'androgene et procede d'utilisation associes - Google Patents

Modulateurs irreversibles selectifs de recepteur d'androgene et procede d'utilisation associes

Info

Publication number
EP1487783A4
EP1487783A4 EP03710820A EP03710820A EP1487783A4 EP 1487783 A4 EP1487783 A4 EP 1487783A4 EP 03710820 A EP03710820 A EP 03710820A EP 03710820 A EP03710820 A EP 03710820A EP 1487783 A4 EP1487783 A4 EP 1487783A4
Authority
EP
European Patent Office
Prior art keywords
irreversible
androgen receptor
selective modulators
modulators
selective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03710820A
Other languages
German (de)
English (en)
Other versions
EP1487783A2 (fr
Inventor
James Dalton
Duane D Miller
Leonid I Kirkovsky
Dong Jin Hwang
Mitchell S Steiner
Karen A Veverka
Arnab Mukherjee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tennessee Research Foundation
Original Assignee
University of Tennessee Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tennessee Research Foundation filed Critical University of Tennessee Research Foundation
Publication of EP1487783A2 publication Critical patent/EP1487783A2/fr
Publication of EP1487783A4 publication Critical patent/EP1487783A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/05Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C261/00Derivatives of cyanic acid
    • C07C261/02Cyanates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C265/00Derivatives of isocyanic acid
    • C07C265/12Derivatives of isocyanic acid having isocyanate groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/02Thiocyanates
    • C07C331/10Thiocyanates having sulfur atoms of thiocyanate groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/16Isothiocyanates
    • C07C331/28Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP03710820A 2002-02-28 2003-02-24 Modulateurs irreversibles selectifs de recepteur d'androgene et procede d'utilisation associes Withdrawn EP1487783A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8467902A 2002-02-28 2002-02-28
US453704P 2002-02-28
US42024802P 2002-10-23 2002-10-23
US420248P 2002-10-23
PCT/US2003/003121 WO2003074473A2 (fr) 2002-02-28 2003-02-24 Modulateurs irreversibles selectifs de recepteur d'androgene et procede d'utilisation associes

Publications (2)

Publication Number Publication Date
EP1487783A2 EP1487783A2 (fr) 2004-12-22
EP1487783A4 true EP1487783A4 (fr) 2006-09-27

Family

ID=27791168

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03710820A Withdrawn EP1487783A4 (fr) 2002-02-28 2003-02-24 Modulateurs irreversibles selectifs de recepteur d'androgene et procede d'utilisation associes

Country Status (12)

Country Link
EP (1) EP1487783A4 (fr)
JP (1) JP2005519111A (fr)
KR (1) KR20040104463A (fr)
CN (1) CN1646479A (fr)
AU (1) AU2003214971A1 (fr)
CA (1) CA2476651A1 (fr)
EA (1) EA200401121A1 (fr)
HR (1) HRP20040851A2 (fr)
IL (1) IL163742A0 (fr)
MX (1) MXPA04008412A (fr)
TW (1) TW200304806A (fr)
WO (1) WO2003074473A2 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040260108A1 (en) * 2001-06-25 2004-12-23 Dalton James T. Metabolites of selective androgen receptor modulators and methods of use thereof
US7253210B2 (en) 2002-10-15 2007-08-07 University Of Tennessee Research Foundation Methylene-bridged selective androgen receptor modulators and methods of use thereof
JP2006518328A (ja) * 2002-10-15 2006-08-10 ユニバーシティ・オブ・テネシー・リサーチ・ファウンデーション 複素環選択的アンドロゲン受容体調節剤及びその使用方法
EP2457892A1 (fr) * 2003-01-13 2012-05-30 University of Tennessee Research Foundation Synthèse à grande échelle des modulateurs du récepteur des androgènes sélectifs
JP2006516286A (ja) * 2003-01-22 2006-06-29 ジーティーエックス・インコーポレイテッド Sarmによる女性のアンドロゲン減少に関連する病気の治療
CA2522874A1 (fr) 2003-12-16 2005-07-07 Gtx, Inc. Promedicaments de modulateurs selectifs des recepteurs aux androgenes et leurs methodes d'utilisation
KR100783255B1 (ko) 2004-02-13 2007-12-06 워너-램버트 캄파니 엘엘씨 안드로젠 수용체 조절제
JP2007532621A (ja) 2004-04-13 2007-11-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲンモジュレータ
WO2005102990A1 (fr) 2004-04-22 2005-11-03 Warner-Lambert Company Llc Modulateurs des androgenes
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
EP1781598A1 (fr) 2004-07-08 2007-05-09 Warner-Lambert Company LLC Modulateurs d'androgenes
MX2007001248A (es) * 2004-08-18 2007-03-23 Warner Lambert Co Moduladores de androgenos.
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
NZ720499A (en) * 2013-12-23 2020-04-24 Bcn Peptides Sa Bicalutamide analogs or (s)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosis
US10093613B2 (en) 2015-04-21 2018-10-09 Gtx, Inc. Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US10654809B2 (en) 2016-06-10 2020-05-19 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US10441570B2 (en) 2015-04-21 2019-10-15 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) Ligands and methods of use thereof
US10865184B2 (en) 2015-04-21 2020-12-15 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US10806720B2 (en) 2015-04-21 2020-10-20 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US11230523B2 (en) 2016-06-10 2022-01-25 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
EP3468552A4 (fr) * 2016-06-10 2020-07-08 University of Tennessee Research Foundation Ligands de sard - composés de dégradation sélectifs de récepteurs des androgènes - et méthodes d'utilisation
WO2020051344A1 (fr) 2018-09-05 2020-03-12 University Of Tennessee Research Foundation Ligands de composés de dégradation sélectifs de récepteurs des androgènes (sard) et procédés d'utilisation associés
CN113137836B (zh) * 2021-04-23 2023-04-07 柳州东风容泰化工股份有限公司 一种制备邻氯苯腈的干燥方法及系统
WO2025102293A1 (fr) * 2023-11-16 2025-05-22 北京脑科学与类脑研究所 Modulateur du récepteur des androgènes neuroactifs et son utilisation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998053826A1 (fr) * 1997-05-30 1998-12-03 The University Of Tennessee Research Corporation Composes agonistes non steroidiens et leur utilisation dans le cadre de therapies a base d'hormones males
WO2002016310A1 (fr) * 2000-08-24 2002-02-28 The University Of Tennessee Research Corporation Modulateurs selectifs du recepteur androgenique et procedes d'utilisation de ces derniers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071957A (en) * 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998053826A1 (fr) * 1997-05-30 1998-12-03 The University Of Tennessee Research Corporation Composes agonistes non steroidiens et leur utilisation dans le cadre de therapies a base d'hormones males
WO2002016310A1 (fr) * 2000-08-24 2002-02-28 The University Of Tennessee Research Corporation Modulateurs selectifs du recepteur androgenique et procedes d'utilisation de ces derniers

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DALTON J T ET AL: "Discovery of nonsteroidal androgens", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 244, no. 1, 1998, pages 1 - 4, XP002385138, ISSN: 0006-291X *
KIRKOVSKY L. ET AL: "Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 43, no. 4, 24 February 2000 (2000-02-24), pages 581 - 590, XP002207426, ISSN: 0022-2623 *

Also Published As

Publication number Publication date
EP1487783A2 (fr) 2004-12-22
TW200304806A (en) 2003-10-16
WO2003074473A3 (fr) 2003-12-18
EA200401121A1 (ru) 2005-10-27
MXPA04008412A (es) 2005-05-17
CN1646479A (zh) 2005-07-27
KR20040104463A (ko) 2004-12-10
JP2005519111A (ja) 2005-06-30
AU2003214971A1 (en) 2003-09-16
HRP20040851A2 (en) 2005-02-28
IL163742A0 (en) 2005-12-18
WO2003074473A2 (fr) 2003-09-12
CA2476651A1 (fr) 2003-09-12

Similar Documents

Publication Publication Date Title
EP1487783A4 (fr) Modulateurs irreversibles selectifs de recepteur d'androgene et procede d'utilisation associes
EP1487780A4 (fr) Composes a substitution haloacetamide et azide et procedes d'utilisation associes
IL165792A0 (en) N-bridged selective androgen receptor modulators and methods of use thereof
EP1613592A4 (fr) Composes acide hydroxamique et techniques d'utilisation de ceux-ci
AU2003251970A8 (en) Modulators of the glucocorticoid receptor and method
DE602004022168D1 (de) Melanocortin-4-rezeptor bindende verbindungen und verfahren zu deren anwendung
DE60109547D1 (de) Hitzeempfindlicher Klebstoff, Verfahren zu dessen Darstellung und Verwendung
AU2003294264A8 (en) Non-steroidal farnesoid x receptor modulators and methods for the use thereof
ATE347213T1 (de) System und verfahren zum integrieren von wlan und 3g
DE60336185D1 (de) MEMS-Bauelemente und Verfahren zu deren Herstellung
DE60336570D1 (de) Kommunikationsvorrichtung und verfahren zum umkonfigurieren der kommunikationsvorrichtung
DE60126537D1 (de) Flüssigkristallprojektor und Verfahren zu dessen Einstellung
DE60113215D1 (de) Halbleitervorrichtung und Verfahren zu dessen Herstellung
EP1750694A4 (fr) Metabolites de modulateurs selectifs du recepteur androgenique, et procede d'utilisation de ceux-ci
DE602005019961D1 (de) Steuervorrichtung und Verfahren zu deren Herstellung
DE60202988D1 (de) Kegelstumpfförmige Stopfvorrichtung und deren Anwendungsverfahren
DE60037328D1 (de) Haltevorrichtung mit druckelementen und verfahren zu ihrer verwendung
IL163744A (en) Multi-substituted selective androgen receptor modulators and uses thereof
DE60218292D1 (de) Tintendruckablagevorrichtung und verfahren
DE50312932D1 (de) Verfahren und schaltungsanordnung zum begrenzen einer überspannung
DE60118897D1 (de) Übertragungsvorrichtung und Verfahren zu dessen Flussteuerung
DE602004029245D1 (de) Indolonacetamidderivate, verfahren zu deren herstellung und deren verwendungen
DE60226707D1 (de) Kunsthaare und verfahren zu deren herstellung
DE602004024735D1 (de) Statische Inbetriebsetzungsprüfungs-Methode und Vorrichtung um den Nennfluss zu identifizieren
DE602004026026D1 (de) Gesteuerte Meldungsvorrichtung, System und Verfahren

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040928

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MUKHERJEE, ARNAB

Inventor name: VEVERKA, KAREN, A.

Inventor name: STEINER, MITCHELL, S.

Inventor name: HWANG, DONG JIN

Inventor name: KIRKOVSKY, LEONID, I.

Inventor name: MILLER, DUANE, D.

Inventor name: DALTON, JAMES

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1068130

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20060824

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060901

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1068130

Country of ref document: HK